1. Adelaide Research & Scholarship

Browsing "University Library" by Author Gabbay, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 13 to 22 of 22 < previous 
PreviewIssue DateTitleAuthor(s)
2012Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort studyNgian, G.; Stevens, W.; Prior, D.; Gabbay, E.; Roddy, J.; Tran, A.; Minson, R.; Hill, C.; Chow, K.; Sahhar, J.; Proudman, S.; Nikpour, M.
2003Pulmonary arterial hypertension: a new era in managementKeogh, A.; McNeil, K.; Williams, T.; Gabbay, E.; Cleland, L.
2015Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.A.; Proudman, S.M.; Goh, N.; Corte, T.J.; Rouse, H.; Hennessy, O.; Morrisroe, K.; Thakkar, V.; Sahhar, J.; Roddy, J.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA)
2013Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung diseaseMoore, O.; Proudman, S.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Sahhar, J.; Roddy, J.E.; Youssef, P.; Gabbay, E.; Nash, P.; Zochling, J.; Stevens, W.; Nikpour, M.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA)
2010Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physiciansMangat, P.; Conron, M.; Gabbay, E.; Proudman, S.M.
2013Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?Nikpour, M.; Stevens, W.; Proudman, S.; Buchbinder, R.; Prior, D.; Zochling, J.; Williams, T.; Gabbay, E.; Nandurkar, H.
2014The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosisMorrisroe, K.; Stevens, W.; Nandurkar, H.; Prior, D.; Thakkar, V.; Roddy, J.; Zochling, J.; Sahhar, J.; Tymms, K.; Sturgess, A.; Major, G.; Kermeen, F.; Hill, C.; Walker, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2011The Bosentan Patient Registry: long-term survival in pulmonary arterial hypertensionKeogh, A.; Strange, G.; McNeil, K.; Williams, T.; Gabbay, E.; Proudman, S.; Weintraub, R.; Wlodarczyk, J.; Dalton, B.
2013The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort studyThakkar, V.; Stevens, W.; Prior, D.; Youssef, P.; Liew, D.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Rischmueller, M.; Proudman, S.; Nikpour, M.
2016The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control studyThakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Sahhar, J.; G Walker, J.; Roddy, J.; Lester, S.; Rischmueller, M.; Zochling, J.; Nash, P.; Gabbay, E.; Youssef, P.; Proudman, S.M.; Nikpour, M.
Showing results 13 to 22 of 22 < previous